StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer DB Geography by Year

DB Geography — International Developed Markets Revenues ($M) ($M)

Pfizer DB Geography: $16,188M in FY2025, up 0.8% from a year earlier.

Latest, FY2025
16,188
Period ended Dec 31, 2025
Change on a year earlier
+0.8%
16,057 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Database (SEC Form 10-K / 10-Q XBRL via lib/db.py).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDB Geography — International Developed Markets Revenues ($M) ($M)Year on yearSource
FY2025Dec 31, 202516,188+0.8%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202416,057-23.2%Form 10-K (filed 2025-02-27) ↗
FY2023Dec 31, 202320,910-48.4%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 202240,534–Form 10-K (filed 2025-02-27) ↗

Cite this data

StockData. (2026). Pfizer DB Geography ($M), annual FY2022–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/db-geo-rev-dev

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.